Arkansas Legal Resource Navigator

15 U.S.C. § 278u — Xylazine detection and analysis

Federal law — U.S. Code and appendices · legal_authorities

15 U.S.C. § 278u — Xylazine detection and analysis

**(a) Definitions** In this section: (1) **Director** — The term “Director” means the Director of the National Institute of Standards and Technology. (2) **Federal laboratory** — The term “Federal laboratory” has the meaning given such term in [section 3703 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section3703&num=0&edition=prelim). (3) **Institute** — The term “Institute” means the National Institute of Standards and Technology. (4) **Institution of higher education** — The term “institution of higher education” has the meaning given such term in [section 1001 of title 20](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title20-section1001&num=0&edition=prelim). (5) **Nonprofit organization** — The term “nonprofit organization” means an organization described in [section 501(c)(3) of title 26](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title26-section501/c/3&num=0&edition=prelim) and exempt from tax under section 501(a) of such title. (6) **Xylazine** — The term “xylazine” means the nonopioid tranquilizer methyl benzene compound frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties. **(b) In general** The Director shall— (1) support intramural basic measurement science and research of the Institute to advance— (A) analytical methods to identify, understand, differentiate, and categorize substances containing xylazine, novel synthetic opioids, or other new psychoactive substances; (B) measurement technologies to shorten analysis timelines and enhance narcotic and opioid detection and analysis capabilities; (C) new data tools, techniques, and processes to identify and publicly disclose relevant information concerning substance

Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 278u

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: e1b9cae3181f48b020670809162a44ca4b96aeb23bf256694ec98147a11d31d1. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_3e0a570c1d1eac013e671931
Source file: Laws/federal/codes/united-states-code/title-15/section-278u-xylazine-detection-and-analysis--2e4f0c3bbe.md
Pages: Not recorded – Not recorded
Passage SHA-256: 17f0740471a4c4d3507bb06216097eefbf06368db9727a04b5b3d7d4f3b763f6

Source location: Title 15, Chapter 7, § 278u; chapter-007-national-institute-of-standards-and-technology.md

Stored source content

**(a) Definitions** In this section: (1) **Director** — The term “Director” means the Director of the National Institute of Standards and Technology. (2) **Federal laboratory** — The term “Federal laboratory” has the meaning given such term in [section 3703 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section3703&num=0&edition=prelim). (3) **Institute** — The term “Institute” means the National Institute of Standards and Technology. (4) **Institution of higher education** — The term “institution of higher education” has the meaning given such term in [section 1001 of title 20](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title20-section1001&num=0&edition=prelim). (5) **Nonprofit organization** — The term “nonprofit organization” means an organization described in [section 501(c)(3) of title 26](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title26-section501/c/3&num=0&edition=prelim) and exempt from tax under section 501(a) of such title. (6) **Xylazine** — The term “xylazine” means the nonopioid tranquilizer methyl benzene compound frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties. **(b) In general** The Director shall— (1) support intramural basic measurement science and research of the Institute to advance— (A) analytical methods to identify, understand, differentiate, and categorize substances containing xylazine, novel synthetic opioids, or other new psychoactive substances; (B) measurement technologies to shorten analysis timelines and enhance narcotic and opioid detection and analysis capabilities; (C) new data tools, techniques, and processes to identify and publicly disclose relevant information concerning substances containing xylazine, novel synthetic opioids, or other new psychoactive substances; and (D) such other areas as the Director determines to be critical to the development and deployment of technologies to measure and analyze the presence of xylazine, novel synthetic opioids, and other new psychoactive substances; (2) support activities to inform and expand the development of near-real time spectrometry capabilities regarding xylazine, novel synthetic opioids, and other new psychoactive substances; (3) convene and consult with organizations engaged in the analysis of new psychoactive substances to develop coordinated strategies and voluntary best practices for the safe handling, transport, data-sharing, and analysis of substances containing xylazine, novel synthetic opioids, or other new psychoactive substances, including— (A) the Drug Enforcement Administration; (B) the Centers for Disease Control and Prevention; (C) the National Institute on Drug Abuse; (D) Federal laboratories; (E) States and territories; (F) State fusion centers; (G) the private sector; (H) intergovernmental organizations; (I) institutions of higher education,11 So in original. The comma probably should be a semicolon. and (J) nonprofit organizations; (4) establish or expand collaborative partnerships or consortia with other government agencies and persons engaged in related research and development, such as institutions of higher education, Federal laboratories, public health agencies, intergovernmental organizations, and the private sector, to enhance narcotic and opioid detection and analysis capabilities regarding xylazine, novel synthetic opioids, and other new psychoactive substances; and (5) encourage graduate and post-graduate research to include detection and identification of xylazine and other new psychoactive substances in relevant course studies when practicable. **(c) Controls** In carrying out activities under this section, the Director shall ensure proper security controls are implemented to protect sensitive information, as the Director considers appropriate and consistent with applicable provisions of law. **(d) Report** Not later than 1 year after December 19, 2023, the Director shall submit to the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Science, Space, and Technology of the House of Representatives a report on the implementation of this section. Such report may include recommendations for legislative action to improve the ability of the Director to carry out this section.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

15 U.S.C. § 3703 — Definitions

As used in this chapter, unless the context otherwise requires, the term— (1) “Secretary” means the Secretary of Commerce. (2) “Centers” means the Cooperative Research Centers established under section 3705 or 3707 of this title. (3) “Nonprofit institution” means an organization owned and operated exclusively for scientific or educational purposes, no part of the net earnings of which inures to the benefit of any private shareholder or individual. (4) “Federal laboratory” means any laboratory, any federally funded research and development center, or any center established under section 3705 or 3707 of this title that is owned, leased, or otherwise used by a Federal agency and funded by the Federal Government, whether operated by the Government or by a contractor. (5) “Supporting agency” means either the Department of Commerce or the National Science Foundation, as appropriate. (6) “Federal agency” means any executive agency as defined in [section 105 of title 5](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title5-section105&num=0&edition=prelim) and the military departments as defined in section 102 of such title, as well as any agency of the legislative branch of the Federal Government. (7) “Invention” means any invention or discovery which is or may be patentable or otherwise protected under title 35 or any novel variety of plant which is or may be protectable under the Plant Variety Protection Act ([7 U.S.C. 2321](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title7-section2321&num=0&edition=prelim) et seq.). (8) “Made” when used in conjunction with any invention means the conception or first actual reduction to practice of such invention. (9) “Small business firm” means a small business concern as defined in [section 632 of th

Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 3703

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

20 U.S.C. § 1001 — General definition of institution of higher education

**(a) Institution of higher education** For purposes of this chapter, other than subchapter IV, the term “institution of higher education” means an educational institution in any State that— (1) admits as regular students only persons having a certificate of graduation from a school providing secondary education, or the recognized equivalent of such a certificate, or persons who meet the requirements of [section 1091(d) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title20-section1091/d&num=0&edition=prelim); (2) is legally authorized within such State to provide a program of education beyond secondary education; (3) provides an educational program for which the institution awards a bachelor’s degree or provides not less than a 2-year program that is acceptable for full credit toward such a degree, or awards a degree that is acceptable for admission to a graduate or professional degree program, subject to review and approval by the Secretary; (4) is a public or other nonprofit institution; and (5) is accredited by a nationally recognized accrediting agency or association, or if not so accredited, is an institution that has been granted preaccreditation status by such an agency or association that has been recognized by the Secretary for the granting of preaccreditation status, and the Secretary has determined that there is satisfactory assurance that the institution will meet the accreditation standards of such an agency or association within a reasonable time. **(b) Additional institutions included** For purposes of this chapter, other than subchapter IV, the term “institution of higher education” also includes— (1) any school that provides not less than a 1-year program of training to prepare students for gainful employment in a re

Source: Supplied U.S. Code snapshot — release unconfirmed · 20 U.S.C. § 1001

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

15 U.S.C. § 271 — Findings and purposes

**(a)** The Congress finds and declares the following: (1) The future well-being of the United States economy depends on a strong manufacturing base and requires continual improvements in manufacturing technology, quality control, and techniques for ensuring product reliability and cost-effectiveness. (2) Precise measurements, calibrations, and standards help United States industry and manufacturing concerns compete strongly in world markets. (3) Improvements in manufacturing and product technology depend on fundamental scientific and engineering research to develop (A) the precise and accurate measurement methods and measurement standards needed to improve quality and reliability, and (B) new technological processes by which such improved methods may be used in practice to improve manufacturing and to assist industry to transfer important laboratory discoveries into commercial products. (4) Scientific progress, public safety, and product compatibility and standardization also depend on the development of precise measurement methods, standards, and related basic technologies. (5) The National Bureau of Standards since its establishment has served as the Federal focal point in developing basic measurement standards and related technologies, has taken a lead role in stimulating cooperative work among private industrial organizations in efforts to surmount technological hurdles, and otherwise has been responsible for assisting in the improvement of industrial technology. (6) The Federal Government should maintain a national science, engineering, and technology laboratory which provides measurement methods, standards, and associated technologies and which aids United States companies in using new technologies to improve products and manufacturing processes. (7) Such

Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 271

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

15 U.S.C. § 278u — Xylazine detection and analysis

Page 704 TITLE 15—COMMERCE AND TRADE § 278u 1 So in original. The comma probably should be a semicolon. § 278u. Xylazine detection and analysis (a) Definitions In this section: (1) Director The term ‘‘Director’’ means the Director of the National Institute of Standards and Tech- nology. (2) Federal laboratory The term ‘‘Federal laboratory’’ has the meaning given such term in section 3703 of this title. (3) Institute The term ‘‘Institute’’ means the National In- stitute of Standards and Technology. (4) Institution of higher education The term ‘‘institution of higher education’’ has the meaning given such term in section 1001 of title 20. (5) Nonprofit organization The term ‘‘nonprofit organization’’ means an organization described in section 501(c)(3) of title 26 and exempt from tax under section 501(a) of such title. (6) Xylazine The term ‘‘xylazine’’ means the nonopioid tranquilizer methyl benzene compound fre- quently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties. (b) In general The Director shall— (1) support intramural basic measurement science and research of the Institute to ad- vance— (A) analytical methods to identify, under- stand, differentiate, and categorize sub- stances containing xylazine, novel synthetic opioids, or other new psychoactive sub- stances; (B) measurement technologies to shorten analysis timelines and enhance narcotic and opioid detection and analysis capabilities; (C) new data tools, techniques, and proc- esses to identify and publicly disclose rel- evant information concerning substances containing xylazine, novel synthetic opioids, or other new psychoactive substances; and (D) such other areas as the Director deter- mines to be critical to the devel

Source: Supplied 2024 U.S. Code historical extraction · 15 U.S.C. § 278u

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.